username: password:     Join free | Forgot password
Add to favorites    中文
home > news and events
Direvo validates BluZyTM technology in collaboration with US Center for Crops Utilization Research

Clicks:451 Date:12/19/12

Cologne, Germany, December 18, 2012. Direvo Industrial Biotechnology GmbH successfully completed the scale up of its first two products BluZyTM-D and BluZyTM-P in collaboration with the Center for Crops Utilization Research (CCUR) and the BioCentury Research Farm (BCRF) at Iowa State University.

A team led by Dr. Larry Johnson, director of CCUR and BCRF, conducted lab-scale and pilot-scale trials to test the effects of the enzyme technology on ethanol production and processed samples of enzyme-modified DDGS and unmodified DDGS for analytical and nutritional comparison purposes.

From this work, Direvo validated the performance of BluZyTM-D that substantially improved nutritional value as compared to commercially available DDGS. The production was further scaled up at BCRF where more than one ton of DDGS was produced for further evaluation in broiler feeding trials at major universities in the US.

BluZyTM-P the second product of Direvo´s BluZyTM product development platform was also evaluated by the experts at BCRF. BluZyTM-P improved process efficiency of ethanol production at multiple steps and significantly simplified back end oil separation.

"The pilot-scale facilities for dry-grind ethanol production at BCRF offered Direvo the ideal opportunity to test this new and unique technology prior to full-scale production,鈥 said Klaudija Milos, Vice President Business Unit Industrial Solutions. 鈥淥ur recent project results demonstrate the validity of our technologies and the economic benefit for two large industries in the US, ethanol and animal production."

Direvo will be exploring various industry opportunities as it proceeds in scaling up the BluZyTM-Technology for commercial operations.

About Direvo Industrial Biotechnology GmbH:
Direvo is a biotechnology company with focus on the biomass conversion industry. Direvo identifies bottlenecks and weaknesses in current industrial processes in this sector and develops and implements biology-based solutions together with large and small industrial partners. Direvo鈥檚 products are newly designed enzymes and microorganisms of the highest quality that provide easy-to-implement, cost-effective solutions. Direvo鈥檚 contribution assures that partners stay competitive and profitable while supporting them to make the future cleaner, greener and safer. More information about Direvo is available on
www.direvo.com.

Contact:
Klaudija Milos
DIREVO Industrial Biotechnology GmbH
Nattermannallee 1
50829 Köln (Cologne)
Germany
Phone +49 221-47448-113
Fax +49 221-47448-111
E-Mail
klaudija.milos@direvo.com
Internet
www.direvo.com

Related News>> more
  • European and US Cellulase Patents granted to Direvo Industrial Biotechnology GmbH5/22/2013
  • M+W Group at AchemAsia 2013 with Integrated Solutions for the Biotech, Chemical, ...5/10/2013
  • Identifying unknown modulators of pain with new phenotypic assays5/10/2013
  • Porvair Sciences Announces Summer Show Program5/9/2013
  • Building Novel DNA Constructs. Find Out How at ASM5/9/2013
  • Medical Diagnostics Company STAT-Diagnostica Secures 22.1 Million USD in Series B Financing5/7/2013
  • Veolia鈥檚 Water Treatment Solutions has been selected in Singapore once again by ...4/30/2013
  • OGT Expands NGS Offering with Targeted Familial Sequencing and Analysis4/30/2013
  • Guangzhou Juneng Achieves CE Certification for Low Temperature Ultra-high Pressure ...4/24/2013
  • AMSBIO:Comprehensive Tissue Biorepository and Collection Services4/24/2013
  • advertisement

    Copyright(C) 2006-2013 bio-equip    E-mail:web@bio-equip.cn   娌狪CP澶06040519鍙